Assessment of impact of SGLT2i on endogenous glucose production, tissue glucose disappearance, and urinary glucose excretion post to glucose ingestion in patients with Type 2 Diabetes
Latest Information Update: 23 Jul 2020
At a glance
- Drugs Dapagliflozin (Primary) ; Exenatide
- Indications Type 2 diabetes mellitus
- Focus Pharmacodynamics
- 23 Jul 2020 New trial record
- 16 Jun 2020 Results presented at the 80th Annual Scientific Sessions of the American Diabetes Association